[Impact of access to antiretroviral therapy in Côte d'Ivoire]. / Bilan de l'accès aux antirétroviraux en Côte d'Ivoire.

In 1998 UNAIDS implemented the national drug access initiative (DAI) in Côte d'Ivoire. The Ivorian government took the DAI over in 2000 with the support of the Global Fund and Presidential Emergency Program For AIDS Relief (PEPFAR). The ensuing affordability of antiretroviral therapy (ART), medical staff training, and healthcare equipment allowed Ministry of Health to improve HIV care throughout the country. Since 2008 ART and follow-up monitoring have been free of charge for people living with HIV/AIDS (PLWHA). In January 2009 a total of 57,833 PLWHA received ART and follow-up at 274 HIV care centers. Use of ART has improved the life expectancy of PLWHA. However morbidity and mortality remained high during the first year of ART implementation with respective frequencies of 5-10% person-year (PY) and 2-3% PY. Morbidity was mainly related to infectious disease (tuberculosis and bacteriaemia) and earlier onset of adverse events (AE). In most cases ART has been well tolerated. The main adverse effects have been anemia, neuropathy, skin toxicity and liver enzyme elevation. The incidence of stage 3/4 AE has been low (< 2 %PY). Although overall compliance has been good (<80%), data among children and adults suggest the need for further work to reinforce support mechanisms. Convincing results have been obtained in the management of PLWHA. Nevertheless greater funding and commitment must be given to management of opportunistic infections and side effects and to development of nutrition support services.

[Three new cases of visceral leishmaniasis in Côte d'Ivoire]. / Trois nouveaux cas de leishmaniose viscérale autochtone en Côte d'Ivoire.

The objective of this work is to report three cases of visceral leishmaniasis in non-HIV infected native patients in Côte d'Ivoire. The three observations concerned adults aged of 31 and 65 and a five years old child without particular medical or surgery histories. Factors associated with visceral leishmaniasis regarding the younger and the older adults were respectively young age, chronic lymphoid leukaemia and Burkitt lymphoma. Clinical features in the three cases were chronic fever a myeloproliferative syndrome with wasting syndrome and pancytopenia. The diagnosis was confirmed by the existence of Leishmania in bone marrow, ganglionic juice and splenic samples. The species of Leishmania was not identified. Specific treatment was based on intravenous amphotericin B (Fungizone) relayed by Glucantim in one case because of side effects; however the treatment has been unsuccessful. These three new cases show that visceral leishmaniasis is a reality in Côte d'Ivoire therefore an epidemiological survey is requested in order to identify Leishmania species, reservoirs and vectors.

[Anemia in the premature newborn]. / Les anemies du premature.

Anemia is a common and life threatening pathology among new born babies from premature. It has the potential to delay the child's growth if appropriate care if not taken. In order to improve care to new born babies with anemia, we carried out a retrospective study on a group of 195 records obtained from the neonatology ward and from 46 outpatients in the CHU of Cocody between January 2001 and December 2003. At the end of the study, we made the following reports: Incidence of early anemia is 17.5% and several risk factors are involved such as absence of anemia and malaria prophylaxis during pregnancy. Anemia whether it is secondary or early is often masked. Palor is observed in small proportions among anemic prematures at birth. Thus, cell blood chemistry is important to confirm the diagnosis. Early anemia is generally normochrome normocytaire and secondary one is hypochronic. Care about anemia cases must rely on clinical data as well as bioiogical and epidemiological data. Early iron supplementation (2 to 3 iron element mg/kg/day) could prevent late and secondary anemia in non-anemic prematures at birth.

[Miliary tuberculosis in children. Report of 89 cases in the pediatric department, Abidjan ]. / La milliaire tuberculeuse chez l'enfant a propos de 89 cas colliges au centre anti tuberculeux d'adjame.

UNLABELLED: The HIV pandemic has led a resurgence of tuberculosis which did reach developing as well as developed countries. In Côte d'Ivoire, tuberculosis represented 40-50 per cent of HIV opportunist infections. The incidence rate of this infection, in 2004 was 110/100,000 inhabitants all type of tuberculosis together. As we know, a few studies haven't been devoted to child military pulmonary tuberculosis. Our objectives in this study are to precise circumstances of diagnosis, to assess treatment of the miliary tuberculosis to children below 15 years, to analyze evolving aspects of military tuberculosis. Retrospective study of medical hill of children center anti tuberculosis from 1st December 1999 to 31st December 2002. In the result, miliary tuberculosis is the third extra pulmonary tuberculosis, and concerns children from 6 to 11 years leaving in the social precarious the age where miliary tuberculosis is the most frequent. HIV seroprevalence rate is 40.62 per cent Clinical signs are: Cough expectoration and impregnation signs among which first have fever, weight loss. The radiological signs are opacity in the shape of seeds of millet. The treatment is efficacy if it is correctly administered. CONCLUSION: Diagnostic of miliary pulmonary tuberculosis is essentially radiologic. The rate of cure of 94% could be improved if health authorities, population and the government combine their efforts to struggle against tuberculosis.

Bilan de l'acces aux antiretroviraux en Cote d'Ivoire

L'initiative nationale d'acces aux antiretroviraux en Cote d`Ivoire a debute en 1998 sous l'egide de l'ONUSIDA. Le relais a ete assure par le gouvernement ivoirien en 2000 avec le soutien du FondsMondial et du PEPFAR (President Emergency Program ForAids Reliefs). L'accessibilite financiere; la formation du personnel de soins et l'equipement des structures sanitaires ont permis la decentralisation de la prise en charge sur tout le territoire national. Depuis aout 2008; le traitement antiretroviral est gratuit de meme que le suivi biologique. Fin janvier 2009; l'on denombrait 57 833 patients sous antiretroviraux; suivis dans 274 centres de prise en charge. L'utilisation des multitherapies antiretrovirales a considerablement modifie le pronostic avec une amelioration de l'esperance de vie des patients infectes par le VIH. Cependant la morbidite et la mortalite restent encore preoccupantes au cours de la premiere annee suivant la mise en route du traitement avec des incidences respectives variant entre 5 et 10patients-annee (PA) et 2 et 3PA. La morbidite est principalement en rapport avec les infections (tuberculose; bacteriemies) et les effets secondaires precoces. Les traitements antiretroviraux sont globalement bien toleres; les principaux effets secondaires etant l'anemie; les neuropathies; les reactions cutanees et les hypertransaminasemies. Les effets secondaires de grade 3 et 4 ont une incidence faible (2PA). L'observance est bonne; estimee a 80; mais des donnees obtenues chez les enfants et sur certains sites de prise en charge incitent a renforcer les dispositifs d'appui a l'observance. Des resultats probants ont ete obtenus dans la prise en charge antiretrovirale des personnes vivant avec l eVIH .Aussi les efforts sont-ils a poursuivre pour le financement et la prise en charge des infections opportunistes et des effets secondaires et pour l'appui nutritionnel

Les infections urinaires neonatales a Abidjan : problematique de la resistance bacterienne

Les infections neonatales sont frequentes avec un taux de letalite de 20 a 70dans les pays en voie de developpement. Parmi ces infections neonatales; l'infection urinaire peut etre grave chez le nouveaune car elle met en jeu aussi bien le pronostic renal; avec l'atrophie ou l'insuffisance renale en l'absence de traitement adequat; que le pronostic vital. Le diagnostic de l'infection urinaire repose sur l'examen cytobacte-riologique des urines. Mais il est rarement effectue a cause de la pauperisation de nos populations. Le but de cette etude etait d'identifier les germes responsables des infections urinaires chez le nouveau-ne afin d'adapter le traitement. Patients et methodes : De juillet a decembre 2004; 720 nouveau-nes hospitalises en neonatalogie au service de pediatrie pour infection neonatale ont fait l'objet de prelevements d'urines en vue d'examen cytobacteriologique. Resultats La culture bacterienne a ete positive pour 136 echantillons soit 18;. Concernant les etiologies des infections urinaires; les bacilles a Gram negatif de la famille des Enterobacteriaceae etaient predominantes avec 77;5contre 26;5pour les cocci a Gram positif Streptococcus et Staphylococcus. La frequence d'isolement dans l'ordre decroissant des enterobacteries etait la suivante : Escherichia coli; Klebsiella; Enterobacter et Levinea avec respectivement 32; 28; 28et 12. Les taux de resistance globale des enterobacteries aux antibiotiques usuels variaient de 66;7a 85;7pour l'amoxicilline associee a l'acide clavulanique ; de 25a 66;7pour la ceftriaxone ; et de 0 a 33;3pour l'amikacine